Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 14,496 | 62,870 | 45,907 | 14,400 | 2,417 |
| Depreciation Amortization | 55,758 | 225,002 | 168,860 | 112,584 | 56,240 |
| Income taxes - deferred | -968 | -25,657 | -15,585 | -3,453 | -539 |
| Accounts receivable | -17,434 | 17,204 | -5,417 | 15,509 | -170 |
| Accounts payable and accrued liabilities | -3,827 | 6,718 | 3,673 | 6,956 | 13,919 |
| Other Working Capital | -23,852 | 3,760 | -30,071 | -21,568 | -15,704 |
| Other Operating Activity | 32,940 | 39,426 | 38,908 | 3,409 | -765 |
| Operating Cash Flow | $57,113 | $329,323 | $206,275 | $127,837 | $55,398 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 20,006 | 65,176 | 45,334 | 30,769 | 17,008 |
| PPE Investments | -270 | -1,740 | -1,051 | -863 | -798 |
| Purchase Of Investment | -18,109 | -126,968 | -87,746 | -42,501 | -25,890 |
| Investing Cash Flow | $1,627 | $-63,532 | $-43,463 | $-12,595 | $-9,680 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 565,175 | N/A | N/A | N/A |
| Debt Repayment | -7,250 | -635,558 | -48,438 | -32,292 | -16,146 |
| Common Stock Issued | 1,341 | 5,643 | 4,658 | 2,366 | 2,058 |
| Common Stock Repurchased | N/A | -25,104 | -25,104 | -25,104 | N/A |
| Other Financing Activity | -15,433 | -20,401 | -19,540 | -18,576 | -11,148 |
| Financing Cash Flow | $-21,342 | $-110,245 | $-88,424 | $-73,606 | $-25,236 |
| Beginning Cash Position | 252,158 | 96,612 | 96,612 | 96,612 | 96,612 |
| End Cash Position | 289,556 | 252,158 | 171,000 | 138,248 | 117,094 |
| Net Cash Flow | $37,398 | $155,546 | $74,388 | $41,636 | $20,482 |
| Free Cash Flow | |||||
| Operating Cash Flow | 57,113 | 329,323 | 206,275 | 127,837 | 55,398 |
| Capital Expenditure | -270 | -1,740 | -1,051 | -863 | -798 |
| Free Cash Flow | 56,843 | 327,583 | 205,224 | 126,974 | 54,600 |